ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,301 | 75.37897 | 1 |
female
| 0 | 12 | 667 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 16 |
$11-$25k
| 0 | 14,949 | null | null | 21.5 |
white
| 22.199219 | 20 | 0.778931 | 0.646973 | 1 | 0 | 0 |
no
| 0.6 | 0.3 |
dnr after sadm
| 3 | 107 | 15.199219 | 110 | 20 | 37.79688 | 323.3125 | null | null | 0.799927 | 150 | 7.389648 | 105 | 26 | 1,350 | 4 | 1 |
no(M2 and SIP pres)
| 1 |
4,302 | 48.47598 | 1 |
male
| 0 | 15 | 211 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
>$50k
| 0 | 17,299 | null | null | 16.666656 |
white
| 17.296875 | 24 | 0.783936 | 0.713989 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 15 | 67 | 6 | 80 | 16 | 35.59375 | null | 3.399902 | 0.799927 | 1 | 136 | null | 119 | 12 | null | 6 | 7 |
SIP>=30
| 7 |
4,303 | 69.33295 | 1 |
female
| 0 | 12 | 436 |
Colon Cancer
|
Cancer
| 2 | 9 | null | 0 | 21,897 | null | null | 19.5 |
hispanic
| 19.398438 | 23 | 0.772949 | 0.528931 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 12 | 69 | null | 68 | 22 | 36 | null | null | null | 1 | 139 | null | 172 | 12 | 5,450 | 3 | 0 |
no(M2 and SIP pres)
| 0 |
4,304 | 38.508 | 0 |
female
| 0 | 12 | 1,074 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 33,349 | null | null | 24.5 |
white
| 27.398438 | 46 | 0.844971 | 0.791992 | 1 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 12 | 105 | 11.298828 | 77 | 26 | 38.09375 | 200 | 4.199219 | 0.299988 | 0.599976 | 140 | 7.379883 | 118 | 6 | 1,180 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,305 | 69.75494 | 0 |
male
| 0 | 15 | 1,074 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 3 |
under $11k
| 0 | 31,384 | null | null | 22.333328 |
black
| 33.195313 | 43 | 0.605957 | 0.416992 | 1 | 0 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 15 | 69 | 14.898438 | 63 | 6 | 38.19531 | 148.96875 | null | null | 4.299805 | 135 | 7.30957 | 87 | 57 | 2,143 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
4,306 | 74.25598 | 0 |
female
| 0 | 23 | 1,074 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 39,642 | null | null | 26 |
white
| 29 | 25 | 0.680908 | 0.586914 | 1 | 1 | 0 |
no
| 0.75 | 0.65 |
no dnr
| 23 | 147 | 13.199219 | 69 | 8 | 36.89844 | 330 | null | null | 0.899902 | 141 | 7.449219 | 185 | 11 | 2,830 | null | 5 |
no(M2 and SIP pres)
| 5 |
4,307 | 64.12897 | 0 |
male
| 0 | 16 | 1,074 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 41 | 38,587 | null | null | 17.666656 |
white
| 29.296875 | 41 | 0.559937 | 0.44696 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 16 | 71 | 13.699219 | 111 | 10 | 39.19531 | 305 | 4.199219 | 0.199982 | 0.399963 | 140 | 7.399414 | 154 | 13 | 1,193 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,308 | 57.43997 | 1 |
male
| 1 | 20 | 20 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 0 | 128,232 | null | null | 43.333313 |
white
| 31.5 | 92 | 0.440979 | 0.320984 | 8 | 1 | 0 |
yes
| 0.8 | 0.7 |
dnr after sadm
| 19 | 97 | 3.899902 | 110 | 20 | 36.89844 | null | 2.599609 | 6.399414 | 1 | 140 | null | 157 | 16 | null | null | 1 |
<2 mo. follow-up
| 1 |
4,309 | 44.36099 | 1 |
female
| 1 | 10 | 10 |
Lung Cancer
|
Cancer
| 1 | 16 | null | 0 | 33,195 | null | null | 29 |
white
| 18.296875 | 23 | 0.72998 | 0.457947 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 10 | 49 | 10.199219 | 68 | 30 | 35.69531 | 110 | null | null | 4 | 147 | 7.359375 | 90 | 89 | 1,945 | null | 0 |
<2 mo. follow-up
| 0 |
4,310 | 56.00299 | 1 |
male
| 0 | 14 | 36 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
$25-$50k
| 0 | 15,116 | null | null | 8 |
white
| 17.296875 | 18 | 0.917969 | 0.861938 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
dnr after sadm
| 12 | 57 | 9.5 | 106 | 4 | 38.09375 | 240 | 3 | null | 1.299805 | 143 | 7.449219 | 148 | 36 | 1,400 | 2 | 0 |
<2 mo. follow-up
| 0 |
4,311 | 72.60797 | 0 |
male
| 0 | 43 | 1,073 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 0 | null | 0 | 60,769 | null | null | 15.75 |
white
| 26.796875 | 40 | 0.73291 | 0.649902 | 1 | 1 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 43 | 49 | 17.5 | 120 | 12 | 35.69531 | 121.65625 | 3.599609 | 0.399963 | 2.799805 | 144 | 7.279297 | 121 | 57 | 560 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
4,312 | 83.95294 | 1 |
female
| 0 | 22 | 63 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
under $11k
| 0 | 68,803 | null | null | 35.333313 |
white
| 31 | 43 | 0.523926 | 0.408997 | 4 | 1 | 0 |
no
| null | null |
no dnr
| 22 | 128 | 13.5 | 134 | 28 | 38.09375 | 206 | 3.699707 | 0.5 | 1.899902 | 142 | 7.319336 | 104 | 96 | 1,240 | null | 4 | null | 4 |
4,313 | 61.71899 | 1 |
male
| 0 | 8 | 231 |
Colon Cancer
|
Cancer
| 1 | 3 |
$11-$25k
| 0 | 10,202 | null | null | 10 |
white
| 15 | 19 | 0.8479 | 0.664917 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 8 | 106 | 5.899414 | 134 | 10 | 37 | 236.65625 | 2.299805 | 19.097656 | 1.399902 | 141 | 7.469727 | 224 | 56 | 3,990 | 1 | 0 |
no(M2 and SIP pres)
| 0 |
4,314 | 59.86298 | 1 |
male
| 0 | 10 | 15 |
Lung Cancer
|
Cancer
| 3 | 4 |
under $11k
| 0 | 7,594 | null | null | 7.5 |
black
| 27.5 | 28 | 0.462952 | 0.148987 | 1 | 0 | 0 |
metastatic
| 0.25 | 0.05 |
dnr after sadm
| 1 | 67 | 7.699219 | 70 | 20 | 36.09375 | null | null | null | 1.5 | 141 | null | 56 | 27 | 2,050 | null | 6 |
<2 mo. follow-up
| 6 |
4,315 | 70.75696 | 1 |
female
| 0 | 7 | 41 |
Colon Cancer
|
Cancer
| 1 | 8 |
under $11k
| 9 | 3,803 | null | null | 7.5 |
black
| 21 | 32 | 0.711914 | 0.430969 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 7 | 55 | 18.097656 | 118 | 30 | 38.29688 | null | 1.799805 | 0.5 | 3.399902 | 131 | null | 299 | 27 | 0 | null | 6 |
<2 mo. follow-up
| 6 |
4,316 | 30.834 | 0 |
female
| 0 | 37 | 1,070 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 65,783 | 42,571.5312 | 38,567 | 17 |
black
| 18.296875 | 19 | 0.932983 | 0.907959 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 37 | 67 | 10.398438 | 60 | 20 | 38.29688 | 98.32812 | null | null | 1.699951 | 141 | 7.509766 | 134 | 27 | 2,075 | 2 | 5 |
SIP>=30
| 5 |
4,317 | 67.24695 | 1 |
male
| 0 | 10 | 699 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 6 |
$11-$25k
| 0 | 29,237 | null | null | 28.5 |
black
| 20 | 18 | 0.839966 | 0.784912 | 2 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 10 | 59 | 24.699219 | 60 | 24 | 35.79688 | null | 3.599609 | 1.099854 | 2.299805 | 141 | null | 102 | 58 | 1,650 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,318 | 25.114 | 0 |
female
| 0 | 12 | 1,069 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 |
$11-$25k
| 0 | 40,468 | null | null | 17 |
black
| 33 | 36 | 0.776978 | 0.704956 | 5 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 12 | 104 | 0.199982 | 125 | 22 | 36.89844 | null | 2.299805 | 0.699951 | 0.5 | 136 | null | 113 | 6 | 5,000 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,319 | 71.96997 | 1 |
female
| 1 | 5 | 5 |
Coma
|
Coma
| 2 | null | null | 61 | 18,530 | null | null | 17 |
white
| 19.898438 | 43 | 0.392944 | 0.319946 | 4 | 1 | 0 |
no
| null | null |
dnr after sadm
| 1 | 38 | 8 | 70 | 16 | 35.79688 | null | 4.699219 | 0.699951 | 1.199951 | 135 | null | 94 | 21 | 3,050 | null | null |
<2 mo. follow-up
| 2.836426 |
4,320 | 52.26599 | 0 |
male
| 0 | 19 | 1,069 |
Colon Cancer
|
Cancer
| 1 | 20 |
>$50k
| 0 | 18,529 | null | null | 14.666664 |
asian
| 37.195313 | 22 | 0.404968 | 0.106995 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 19 | 77 | 10.398438 | 60 | 20 | 35.59375 | null | null | null | 1.699951 | 135 | null | 125 | 33 | 1,150 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,321 | 25.96599 | 1 |
female
| 0 | 8 | 203 |
Colon Cancer
|
Cancer
| 1 | 14 |
$11-$25k
| 0 | 14,354 | null | null | 10 |
black
| 14.798828 | 16 | 0.895996 | 0.761963 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 8 | 114 | 9.099609 | 53 | 28 | 38.19531 | 225.6875 | 3.899902 | 0.399963 | 1.099854 | 139 | 7.399414 | 108 | 18 | 2,700 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,322 | 37.25098 | 1 |
male
| 0 | 12 | 540 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
$11-$25k
| 0 | 24,578 | null | null | 25 |
white
| 23.398438 | 27 | 0.873901 | 0.790894 | 1 | 0 | 0 |
yes
| 0.8 | 0.7 |
no dnr
| 12 | 80 | 6.599609 | 70 | 20 | 36.79688 | 315.375 | null | null | 1.199951 | 139 | 7.319336 | 95 | 23 | 1,150 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
4,323 | 67.14899 | 1 |
female
| 0 | 5 | 291 |
Lung Cancer
|
Cancer
| 1 | 14 | null | 0 | 7,070 | null | null | 12 |
white
| 17.796875 | 16 | 0.685913 | 0.392944 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 5 | 100 | 6.5 | 80 | 25 | 36 | null | 3.299805 | null | 1.299805 | 146 | null | 88 | 24 | 1,500 | 4 | 1 |
no(M2 and SIP pres)
| 1 |
4,324 | 57.19098 | 0 |
male
| 0 | 11 | 1,069 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 10 |
$11-$25k
| 0 | 18,074 | null | null | 14.5 |
black
| 25.898438 | 36 | 0.834961 | 0.730957 | 1 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 11 | 100 | 7.799805 | 70 | 20 | 36.09375 | null | 3.099609 | 0.5 | 1.299805 | 144 | null | 103 | 16 | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,325 | 67.56494 | 0 |
male
| 0 | 11 | 1,069 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
$25-$50k
| 0 | 11,944 | null | null | 13 |
white
| 18 | 10 | 0.873901 | 0.790894 | 1 | 1 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 11 | 63 | 7.299805 | 80 | 20 | 37.09375 | 458.3125 | null | null | 1.599854 | 142 | 7.359375 | 111 | 21 | 1,300 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,326 | 51.88498 | 1 |
female
| 1 | 9 | 9 |
Lung Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 35,326 | null | null | 33 |
white
| 20 | 23 | 0.677979 | 0.381958 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 9 | 63 | 29.097656 | 80 | 7 | 38 | 214 | null | null | 3.199707 | 142 | 7.399414 | 111 | 35 | 3,336 | null | 1 |
<2 mo. follow-up
| 1 |
4,327 | 82.53497 | 1 |
female
| 0 | 17 | 19 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 | null | 0 | 75,513 | null | null | 22.666656 |
white
| 19.699219 | 37 | 0.691895 | 0.599976 | 13 | 0 | 0 |
yes
| 0.25 | 0.15 |
dnr after sadm
| 1 | 65 | 14.298828 | 106 | 24 | 36.39844 | 248 | null | null | 0.799927 | 136 | 7.359375 | 105 | 21 | 1,100 | null | 6 |
<2 mo. follow-up
| 6 |
4,328 | 84.23499 | 1 |
male
| 0 | 13 | 99 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 0 | 18,640 | null | null | 13.5 |
black
| 28 | 52 | 0.650879 | 0.550903 | 1 | 0 | 0 |
no
| 0.25 | 0.2 |
dnr after sadm
| 2 | 119 | 5.699219 | 114 | 27 | 36.59375 | 140.8125 | null | 15 | 5 | 154 | 7.479492 | 104 | 78 | 3,560 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,329 | 61.22699 | 1 |
female
| 0 | 17 | 40 |
Lung Cancer
|
Cancer
| 1 | 18 |
>$50k
| 0 | 25,452 | null | null | 8.666664 |
white
| 21 | 19 | 0.630981 | 0.31897 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 17 | 75 | 26.199219 | 120 | 48 | 38.29688 | 185 | null | null | 1.599854 | 138 | 7.449219 | 123 | 20 | 2,190 | 0 | 0 |
<2 mo. follow-up
| 0 |
4,330 | 56.797 | 1 |
male
| 1 | 4 | 4 |
MOSF w/Malig
|
ARF/MOSF
| 2 | null | null | 0 | 71,320 | null | null | 36 |
black
| 36.09375 | 89 | 0.184998 | 0.095993 | 28 | 0 | 0 |
metastatic
| 0.1 | 0.05 |
dnr after sadm
| 2 | 73 | 13.5 | 124 | 36 | 39 | 211.40625 | 2.299805 | 0.599976 | 0.399963 | 134 | 7.459961 | 123 | 5 | 3,425 | null | null |
<2 mo. follow-up
| 2.660156 |
4,331 | 63.655 | 1 |
male
| 1 | 41 | 41 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
$11-$25k
| 37 | 168,511 | 112,099.5 | 88,988 | 31.5 |
white
| 30 | 44 | 0.280945 | 0.171997 | 12 | 0 | 0 |
metastatic
| 0.2 | 0.2 |
dnr after sadm
| 33 | 65 | 4.399414 | 106 | 28 | 36.69531 | 340 | 2.599609 | 18.898438 | 2.5 | 134 | 7.149414 | 114 | 67 | 75 | null | 1 |
<2 mo. follow-up
| 1 |
4,332 | 63.01199 | 1 |
female
| 1 | 47 | 47 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 4 |
under $11k
| 0 | 266,672 | null | null | 44.75 |
white
| 31.097656 | 45 | 0.536987 | 0.421997 | 10 | 0 | 0 |
yes
| 0.9 | 0.9 |
dnr after sadm
| 38 | 0 | 11.5 | 0 | 0 | 38.89844 | 151.65625 | null | null | 2 | 137 | 7.239258 | 203 | 35 | 4,135 | null | 4 |
<2 mo. follow-up
| 4 |
4,333 | 62.20099 | 1 |
male
| 0 | 3 | 958 |
Colon Cancer
|
Cancer
| 1 | 12 | null | 0 | null | null | null | 4 |
white
| 15.5 | 16 | 0.840942 | 0.650879 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 3 | 72 | 6.5 | 54 | 22 | 35.79688 | null | null | null | 2.099609 | 135 | null | 100 | 79 | 1,000 | null | null |
no(M2 and SIP pres)
| 1.689697 |
4,334 | 47.95297 | 1 |
male
| 1 | 26 | 26 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 12 |
under $11k
| 0 | 124,393 | null | null | 37.25 |
white
| 30.296875 | 72 | 0.685913 | 0.518921 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 22 | 113 | 23 | 106 | 10 | 36 | null | 2.099609 | 4 | 1.099854 | 137 | null | 94 | 13 | 990 | null | 0 |
<2 mo. follow-up
| 0 |
4,335 | 82.06995 | 1 |
female
| 0 | 12 | 14 |
Lung Cancer
|
Cancer
| 3 | null |
$11-$25k
| 9 | 9,039 | null | null | 7.5 |
white
| 22.296875 | 27 | 0.491943 | 0.171997 | 1 | 0 | 1 |
metastatic
| 0.7 | 0.1 |
dnr before sadm
| 0 | 119 | 14.5 | 100 | 24 | 35.59375 | null | null | 0.399963 | 0.599976 | 133 | null | 160 | 9 | 3,700 | null | 3 |
<2 mo. follow-up
| 3 |
4,336 | 62.28299 | 0 |
female
| 0 | 9 | 1,060 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 8 |
under $11k
| 0 | 6,597 | null | null | 8 |
white
| 16.097656 | 12 | 0.902954 | 0.836914 | 1 | 0 | 0 |
no
| 0.99 | 0.95 |
no dnr
| 9 | 100 | 17.296875 | 60 | 29 | 38.79688 | 217.125 | null | null | 0.799927 | 137 | 7.459961 | 105 | 10 | 5,710 | 1 | 2 |
SIP>=30
| 2 |
4,337 | 65.70294 | 1 |
male
| 0 | 87 | 773 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | null | null | 44 | 272,666 | 192,386.125 | 160,300 | 35.25 | null | 22.097656 | 29 | 0.717896 | 0.560913 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 87 | 97 | 17.5 | 65 | 8 | 38 | 362.8125 | null | null | 5.5 | 141 | 7.439453 | 274 | 110 | 625 | null | null |
Coma or Intub
| 2.80957 |
4,338 | 62.43399 | 1 |
male
| 0 | 6 | 233 |
Colon Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 9,179 | null | null | 8 |
white
| 14.199219 | 2 | 0.85498 | 0.678955 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.5 |
no dnr
| 6 | 119 | 12.199219 | 66 | 24 | 38.59375 | 368 | 2.599609 | 0.799927 | 1.299805 | 133 | 7.449219 | 87 | 25 | 6,110 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,339 | 79.98096 | 1 |
female
| 1 | 3 | 3 |
Coma
|
Coma
| 2 | null | null | 100 | 21,247 | null | null | 16 |
other
| 76.6875 | 73 | 0 | 0 | 4 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 36 | 57.796875 | 224 | 32 | 36.09375 | 41 | 2.099609 | 0.699951 | 1.799805 | 135 | 7.30957 | 123 | 50 | 580 | null | null |
<2 mo. follow-up
| 1.878662 |
4,340 | 52.51498 | 1 |
female
| 0 | 25 | 226 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 13 | null | 0 | 67,737 | null | null | 24.25 |
white
| 23.898438 | 54 | 0.834961 | 0.778931 | 2 | 0 | 0 |
no
| 0.85 | 0.8 |
no dnr
| 25 | 55 | 65.6875 | 140 | 21 | 38.09375 | 133.3125 | 1.599854 | 0.799927 | 1.5 | 142 | 7.429688 | 136 | 22 | 1,400 | null | 3 |
adl>=4 (>=5 if sur)
| 3 |
4,341 | 84.07697 | 1 |
female
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
under $11k
| 9 | 35,499 | null | null | 32 |
black
| 30.398438 | 47 | 0.553955 | 0.440979 | 1 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 10 | 87 | 5.899414 | 74 | 16 | 36.59375 | null | null | 1 | 1.099854 | 140 | null | 126 | 9 | 4,500 | null | 5 |
<2 mo. follow-up
| 5 |
4,342 | 80.16394 | 1 |
male
| 1 | 38 | 38 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 3 |
under $11k
| 9 | 177,245 | null | null | 27.25 |
other
| 30.699219 | 54 | 0.355957 | 0.238983 | 32 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 22 | 51 | 16.898438 | 116 | 34 | 39.59375 | 124.4375 | null | 3.399902 | 1.599854 | 136 | 7.399414 | 249 | 33 | 2,655 | null | 7 |
<2 mo. follow-up
| 7 |
4,343 | 50.03699 | 1 |
male
| 1 | 21 | 21 |
Coma
|
Coma
| 1 | 14 |
$11-$25k
| 55 | 17,795 | null | null | 12.666664 |
white
| 24.898438 | 27 | 0.55896 | 0.491943 | 1 | 0 | 0 |
no
| 0.5 | 0.25 |
dnr after sadm
| 2 | 73 | 11.398438 | 110 | 46 | 38.69531 | 182.84375 | null | 0.399963 | 0.399963 | 131 | 7.519531 | 148 | 15 | 2,180 | null | 5 |
<2 mo. follow-up
| 5 |
4,344 | 72.51196 | 0 |
male
| 0 | 24 | 1,056 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 16 |
$11-$25k
| 0 | 6,038 | null | null | 27 |
black
| 22.199219 | 37 | 0.797974 | 0.674927 | 1 | 0 | 0 |
no
| 0.4 | 0.35 |
no dnr
| 24 | 109 | 10.099609 | 124 | 33 | 38 | 164.4375 | 3.099609 | 1.199951 | 0.5 | 137 | 7.459961 | 130 | 14 | 3,555 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,345 | 67.45496 | 1 |
male
| 0 | 13 | 24 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 0 | 37,913 | null | null | 9.5 |
white
| 17.796875 | 21 | 0.876953 | 0.795898 | 1 | 0 | 0 |
no
| 0.85 | 0.75 |
no dnr
| 13 | 112 | 10.599609 | 54 | 8 | 38.29688 | null | 2.699707 | null | 0.799927 | 138 | 7.429688 | 146 | 4 | 3,200 | 0 | 1 |
<2 mo. follow-up
| 1 |
4,346 | 44.63498 | 1 |
male
| 0 | 7 | 258 |
Lung Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 14,703 | null | null | 8.5 |
white
| 9.298828 | 5 | 0.858887 | 0.685913 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 7 | 116 | 14.298828 | 112 | 26 | 36.39844 | 186.65625 | 2.399902 | 0.699951 | 1.399902 | 140 | 7.489258 | 279 | 31 | 3,025 | 0 | 4 |
no(M2 and SIP pres)
| 4 |
4,347 | 76.16394 | 0 |
male
| 0 | 9 | 1,055 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 3 |
under $11k
| 9 | 23,055 | null | null | 17 |
black
| 21.898438 | 23 | 0.774902 | 0.702881 | 1 | 0 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 9 | 62 | 5 | 104 | 23 | 37.89844 | 91.25 | 2.099609 | 9.398438 | 1 | 147 | 7.539062 | 424 | 30 | 1,790 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,348 | 46.26099 | 0 |
male
| 0 | 7 | 1,056 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 7 |
under $11k
| 0 | 18,417 | null | null | 5 |
white
| 15.398438 | 18 | 0.934937 | 0.888916 | 1 | 0 | 0 |
no
| 0.85 | 0.8 |
no dnr
| 7 | 103 | 12.398438 | 112 | 24 | 36 | 414.25 | 3.199707 | 0.399963 | 1.199951 | 141 | 7.429688 | 137 | 24 | 2,300 | null | 3 |
no(M2 and SIP pres)
| 3 |
4,349 | 62.543 | 1 |
female
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 20 | null | 0 | 75,022 | null | null | 42 |
white
| 32.796875 | 56 | 0.564941 | 0.453979 | 14 | 0 | 0 |
no
| 0.6 | 0.5 |
dnr after sadm
| 5 | 120 | 7.699219 | 80 | 24 | 35.5 | 200 | null | 0.699951 | 1.299805 | 140 | 7.429688 | 118 | 26 | 2,500 | null | 6 |
<2 mo. follow-up
| 6 |
4,350 | 37.314 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 |
under $11k
| 0 | 51,971 | null | null | 55 |
white
| 32.296875 | 46 | 0.781982 | 0.710938 | 1 | 0 | 0 |
no
| 0.4 | 0.3 |
no dnr
| 6 | 124 | 16.097656 | 106 | 11 | 37.59375 | 356.625 | null | 0.5 | 1.199951 | 141 | 7.389648 | 116 | 12 | 1,555 | null | 0 |
<2 mo. follow-up
| 0 |
4,351 | 66.53796 | 1 |
male
| 1 | 23 | 23 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 15 |
$11-$25k
| 0 | 188,481 | null | null | 47.333313 |
white
| 36.59375 | 61 | 0.247986 | 0.144989 | 15 | 0 | 0 |
yes
| 0.5 | 0.3 |
dnr after sadm
| 21 | 65 | 17.898438 | 20 | 50 | 38.79688 | 226.65625 | 2.799805 | 0.399963 | 0.799927 | 145 | 7.439453 | 176 | 8 | 2,150 | null | 0 |
<2 mo. follow-up
| 0 |
4,352 | 63.784 | 0 |
male
| 0 | 6 | 1,054 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 21,519 | null | null | 22 |
white
| 15.298828 | 22 | 0.893921 | 0.856934 | 2 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 6 | 125 | 68.5 | 134 | 28 | 35.5 | 190 | 2.899902 | 0.599976 | 0.899902 | 144 | 7.379883 | 184 | 20 | 2,880 | 1 | 6 |
no(M2 and SIP pres)
| 6 |
4,353 | 69.16394 | 1 |
male
| 1 | 87 | 87 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 7 |
under $11k
| 44 | 217,056 | 145,305 | 126,986 | 39.75 |
white
| 25.097656 | 37 | 0.46698 | 0.347961 | 6 | 1 | 0 |
yes
| 0.2 | 0.2 |
dnr after sadm
| 85 | 91 | 24 | 76 | 24 | 36.29688 | 171.40625 | null | 1.099854 | 3.299805 | 131 | 7.449219 | 168 | 55 | 4,435 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,354 | 67.49298 | 1 |
male
| 0 | 6 | 298 |
Colon Cancer
|
Cancer
| 1 | 15 |
$25-$50k
| 0 | 7,680 | null | null | 12 |
white
| 10.599609 | 10 | 0.883911 | 0.736938 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 6 | 105 | 12.699219 | 160 | 26 | 38.59375 | 125 | 2.699707 | 0.699951 | 0.599976 | 141 | 7.459961 | 222 | 14 | 1,785 | 1 | 4 |
no(M2 and SIP pres)
| 4 |
4,355 | 58.50198 | 1 |
male
| 1 | 4 | 4 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 42,141 | null | null | 44 |
white
| 43.195313 | 115 | 0.109985 | 0.046997 | 11 | 0 | 0 |
yes
| 0.05 | 0 |
dnr after sadm
| 4 | 61 | 0.199982 | 186 | 36 | 38.59375 | 275.5 | 1.899902 | 1 | 1.699951 | 140 | 7.419922 | 200 | 34 | 650 | null | null |
<2 mo. follow-up
| 1.979981 |
4,356 | 73.26794 | 1 |
male
| 1 | 59 | 59 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
under $11k
| 0 | 225,766 | 150,638.875 | 123,097 | 35.75 |
white
| 25.097656 | 32 | 0.68396 | 0.590942 | 16 | 0 | 0 |
no
| 0.05 | 0.02 |
dnr after sadm
| 49 | 87 | 1.799805 | 120 | 22 | 37.79688 | 314.25 | null | 0.799927 | 0.799927 | 136 | 7.509766 | 101 | 8 | 3,050 | null | 1 |
<2 mo. follow-up
| 1 |
4,357 | 69.28998 | 1 |
male
| 1 | 6 | 6 |
Coma
|
Coma
| 2 | 12 |
$25-$50k
| 89 | 23,434 | null | null | 26 |
white
| 16 | 7 | 0.402954 | 0.328979 | 3 | 1 | 0 |
no
| 0 | 0 |
dnr after sadm
| 2 | 107 | 13.898438 | 104 | 20 | 36.19531 | 284 | 3.799805 | 0.599976 | 1.199951 | 139 | 7.359375 | 150 | 28 | null | null | 0 |
<2 mo. follow-up
| 0 |
4,358 | 72.36395 | 1 |
male
| 1 | 63 | 63 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 |
>$50k
| 89 | 149,405 | 94,173.8125 | 91,506 | 26.25 |
white
| 22 | 41 | 0.271973 | 0.164978 | 13 | 0 | 0 |
yes
| 0.5 | 0.3 |
dnr after sadm
| 63 | 112 | 13.398438 | 114 | 12 | 36.79688 | 182 | null | null | 1.599854 | 144 | 7.329102 | 69 | 30 | 4,415 | null | 4 | null | 4 |
4,359 | 42.21198 | 1 |
male
| 0 | 8 | 636 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 0 | 14,313 | null | null | 10 |
white
| 16.597656 | 8 | 0.93396 | 0.886963 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 8 | 111 | 13.898438 | 116 | 25 | 38.09375 | 151 | 3 | 0.399963 | 3.599609 | 137 | 7.379883 | 244 | 54 | 3,265 | 7 | 0 |
no(M2 and SIP pres)
| 0 |
4,360 | 56.48199 | 1 |
male
| 0 | 5 | 18 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 50,879 | null | null | 29 |
white
| 18.097656 | 35 | 0.899902 | 0.831909 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 5 | 75 | 3.799805 | 74 | 18 | 36.69531 | null | 3.699707 | 0.599976 | 2.099609 | 140 | null | 88 | 13 | 4,350 | null | null |
<2 mo. follow-up
| 1.866455 |
4,361 | 25.64499 | 0 |
male
| 0 | 20 | 1,047 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 14 |
$11-$25k
| 0 | 49,765 | null | null | 22 |
white
| 28.699219 | 50 | 0.916992 | 0.859985 | 3 | 0 | 0 |
no
| 0.4 | 0.4 |
no dnr
| 20 | 70 | 13 | 70 | 16 | 35 | null | 2.899902 | 1.199951 | 1.099854 | 133 | null | 120 | 61 | 1,400 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,362 | 67.89294 | 0 |
male
| 0 | 22 | 1,046 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 0 | 65,432 | null | null | 34.333313 |
white
| 25.398438 | 53 | 0.780884 | 0.650879 | 1 | 0 | 0 |
no
| 0.78 | 0.7 |
no dnr
| 22 | 71 | 25.5 | 100 | 20 | 37.69531 | null | null | null | 1.799805 | 135 | null | 58 | 17 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
4,363 | 70.57397 | 0 |
male
| 0 | 11 | 1,046 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$25-$50k
| 0 | 22,068 | null | null | 10.5 |
white
| 13.599609 | 20 | 0.904907 | 0.839966 | 1 | 0 | 0 |
no
| 0.95 | 0.75 |
no dnr
| 11 | 81 | 9.898438 | 130 | 24 | 37.89844 | 253.3125 | 2.299805 | 0.5 | 0.899902 | 139 | 7.40918 | 143 | 8 | 4,870 | 0 | 2 |
no(M2 and SIP pres)
| 2 |
4,364 | 60.22998 | 0 |
male
| 0 | 7 | 1,046 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
>$50k
| 0 | 12,106 | null | null | 6 |
white
| 16 | 22 | 0.907959 | 0.844971 | 1 | 1 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 7 | 131 | 6.899414 | 54 | 14 | 37.59375 | 157.5 | null | null | 0.899902 | 138 | 7.389648 | 121 | 7 | 6,915 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,365 | 50.37399 | 0 |
female
| 0 | 38 | 1,045 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 0 | 220,001 | 143,696.125 | 117,379 | 20.25 |
black
| 23.796875 | 30 | 0.793945 | 0.725952 | 36 | 1 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 38 | 107 | 15 | 120 | 44 | 38.29688 | 63.32812 | null | null | 0.699951 | 138 | 7.379883 | 69 | 7 | 1,270 | null | 2 |
no(M2 and SIP pres)
| 2 |
4,366 | 28.709 | 1 |
female
| 0 | 4 | 170 |
Colon Cancer
|
Cancer
| 1 | 15 |
$25-$50k
| 0 | 2,712 | null | null | 10 |
white
| 18.296875 | 17 | 0.859985 | 0.688965 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.15 |
no dnr
| 4 | 109 | 6.699219 | 96 | 22 | 35.79688 | 352 | null | null | 11.599609 | 138 | 7.429688 | 152 | 89 | 0 | 0 | 0 | null | 0 |
4,367 | 69.91095 | 1 |
male
| 0 | 7 | 56 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 3,738 | null | null | 5.5 |
white
| 24.097656 | 41 | 0.792969 | 0.667969 | 1 | 1 | 0 |
no
| 0.95 | 0.75 |
no dnr
| 7 | 121 | 14.699219 | 100 | 8 | 36.09375 | 380 | 2 | 0.599976 | 0.699951 | 135 | 7.379883 | 274 | 8 | 1,270 | null | null |
<2 mo. follow-up
| 2.931152 |
4,368 | 23.10699 | 0 |
female
| 0 | 8 | 1,045 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 24,572 | null | null | 17.5 |
black
| 17.898438 | 26 | 0.94397 | 0.922974 | 1 | 1 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 8 | 73 | 7.599609 | 60 | 16 | 39.19531 | null | null | null | null | 138 | null | 143 | 6 | 1,390 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,369 | 69.54095 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 100 | 58,201 | null | null | 53 |
white
| 56.09375 | 95 | 0 | 0 | 2 | 0 | 0 |
no
| 0 | 0 |
dnr after sadm
| 5 | 71 | 12.798828 | 106 | 24 | 36.89844 | 409.5 | null | null | 1.5 | 129 | 7.5 | 181 | 37 | 4,600 | null | null |
<2 mo. follow-up
| 2.704102 |
4,370 | 81.68396 | 1 |
male
| 0 | 26 | 363 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
$11-$25k
| 0 | 53,116 | null | null | 16 |
white
| 26.296875 | 50 | 0.576904 | 0.382996 | 7 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 26 | 130 | 10.199219 | 108 | 20 | 36.69531 | null | null | 0.5 | 0.899902 | 141 | null | 122 | 16 | 5,900 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,371 | 65.53894 | 1 |
male
| 0 | 6 | 191 |
Colon Cancer
|
Cancer
| 2 | 8 |
under $11k
| 0 | 5,489 | null | null | 7 |
black
| 19.597656 | 17 | 0.778931 | 0.537964 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.2 |
no dnr
| 6 | 139 | 43.09375 | 120 | 35 | 36.19531 | 264 | null | null | 0.899902 | 141 | 7.329102 | 170 | 14 | 2,325 | null | 5 | null | 5 |
4,372 | 83.99695 | 1 |
male
| 0 | 5 | 349 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 | null | 0 | 9,379 | null | null | 15 |
white
| 19.199219 | 31 | 0.80896 | 0.689941 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 5 | 70 | 7.5 | 100 | 16 | 36 | 423.75 | null | null | 1.299805 | 139 | 7.449219 | 228 | 14 | 2,380 | null | 3 |
no(M2 and SIP pres)
| 3 |
4,373 | 66.24194 | 1 |
female
| 0 | 14 | 27 |
Lung Cancer
|
Cancer
| 2 | 15 |
under $11k
| 0 | 21,273 | null | null | 12.666664 |
white
| 25.296875 | 39 | 0.50293 | 0.181976 | 1 | 0 | 0 |
metastatic
| 0.85 | 0.78 |
no dnr
| 14 | 109 | 8.099609 | 126 | 24 | 38.29688 | 368 | null | null | 0.699951 | 133 | 7.379883 | 131 | 6 | 865 | null | null |
<2 mo. follow-up
| 3.279297 |
4,374 | 51.46597 | 0 |
female
| 0 | 45 | 1,040 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 8 |
$25-$50k
| 0 | 98,005 | null | null | 14.25 |
white
| 19.597656 | 23 | 0.730957 | 0.578979 | 19 | 0 | 0 |
yes
| 1 | 1 |
no dnr
| 45 | 125 | 9.398438 | 120 | 24 | 38.59375 | null | 1.799805 | 0.799927 | 0.599976 | 135 | null | 148 | 31 | null | null | 1 |
no(M2 and SIP pres)
| 1 |
4,375 | 63.47998 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 26 | 64,614 | null | null | 33 |
white
| 26.796875 | 47 | 0.589966 | 0.480957 | 16 | 0 | 0 |
no
| 0.1 | 0.05 |
dnr after sadm
| 5 | 122 | 11.298828 | 70 | 10 | 35.29688 | 428.5625 | null | 2 | 2.899902 | 141 | 7.289062 | 126 | 66 | 2,875 | null | 0 |
<2 mo. follow-up
| 0 |
4,376 | 72.10699 | 1 |
male
| 1 | 126 | 126 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 9 |
$11-$25k
| 0 | 412,406 | 299,965.75 | 246,904 | 31.75 |
white
| 49 | 58 | 0.140991 | 0.032997 | 1 | 0 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 93 | 80 | 20.5 | 118 | 16 | 36 | null | 3.599609 | 0.399963 | 0.899902 | 136 | null | 110 | 22 | 5,650 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,377 | 24.05699 | 0 |
female
| 0 | 23 | 1,037 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 0 | 87,463 | null | null | 30 |
white
| 19.398438 | 14 | 0.92395 | 0.895996 | 4 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 23 | 58 | 31.5 | 140 | 35 | 38 | 146.9375 | 2 | 1.299805 | 4 | 146 | 7.349609 | 108 | 67 | 5 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,378 | 77.30896 | 1 |
male
| 1 | 9 | 9 |
Coma
|
Coma
| 1 | 9 | null | 61 | 31,303 | null | null | 32 |
white
| 22.199219 | 43 | 0.33197 | 0.259949 | 1 | 1 | 0 |
no
| 0.05 | 0.02 |
dnr after sadm
| 6 | 149 | 1.599854 | 124 | 25 | 37.79688 | 177.5 | null | 0.799927 | 1.299805 | 142 | 7.429688 | 159 | 53 | 3,615 | null | null |
<2 mo. follow-up
| 2.285156 |
4,379 | 22.116 | 1 |
female
| 1 | 30 | 30 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 195,681 | 59,831.8125 | 110,839 | 52.5 |
black
| 42.09375 | 105 | 0.666992 | 0.569946 | 1 | 0 | 0 |
no
| 0.15 | 0.15 |
dnr after sadm
| 30 | 64 | 16.199219 | 126 | 40 | 36.39844 | 147.5 | null | null | 0.799927 | 149 | 7.399414 | 168 | 20 | 1,245 | null | 0 |
<2 mo. follow-up
| 0 |
4,380 | 61.487 | 1 |
male
| 0 | 39 | 431 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 8 |
$11-$25k
| 44 | 99,152 | null | null | 24 |
black
| 31.699219 | 47 | 0.369995 | 0.251953 | 22 | 1 | 0 |
no
| 0.2 | 0.15 |
no dnr
| 39 | 80 | 5.299805 | 76 | 12 | 35.59375 | null | null | 0.399963 | 1 | 142 | null | 126 | 17 | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,381 | 43.65799 | 0 |
female
| 0 | 24 | 1,036 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 0 | 42,531 | null | null | 13.666664 |
white
| 30.199219 | 21 | 0.790894 | 0.7229 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 24 | 53 | 12.798828 | 140 | 10 | 38.29688 | 280 | 3.099609 | 11.5 | 1.099854 | 139 | 7.509766 | 156 | 39 | 1,505 | null | 0 | null | 0 |
4,382 | 61.465 | 1 |
male
| 1 | 53 | 53 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 15 |
$11-$25k
| 0 | 261,018 | 170,933.125 | 151,400 | 38 |
white
| 27.199219 | 34 | 0.667969 | 0.571899 | 5 | 0 | 0 |
yes
| 1 | 1 |
no dnr
| 53 | 81 | 13.398438 | 76 | 20 | 36.59375 | null | null | null | 2.5 | 152 | null | 178 | 55 | 1,850 | null | 0 |
<2 mo. follow-up
| 0 |
4,383 | 56.23798 | 1 |
female
| 1 | 33 | 33 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 17 |
$25-$50k
| 0 | 52,458 | null | null | 19 |
white
| 23.699219 | 39 | 0.651978 | 0.552979 | 1 | 0 | 0 |
metastatic
| 0.15 | 0.05 |
dnr after sadm
| 27 | 80 | 8.099609 | 76 | 20 | 35.5 | null | 4.099609 | 0.399963 | 0.299988 | 138 | null | 91 | 14 | 1,400 | null | 6 |
<2 mo. follow-up
| 6 |
4,384 | 77.22095 | 1 |
female
| 1 | 4 | 4 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
under $11k
| 26 | 59,938 | null | null | 40 |
white
| 57.796875 | 81 | 0 | 0 | 15 | 0 | 0 |
metastatic
| 0.02 | 0.02 |
dnr after sadm
| 4 | 116 | 18.699219 | 146 | 11 | 38 | 270 | 3.199707 | 0.399963 | 1.299805 | 136 | 7.459961 | 165 | 23 | 2,580 | null | 1 |
<2 mo. follow-up
| 1 |
4,385 | 78.04797 | 1 |
female
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 26 | 112,976 | null | null | 56 |
black
| 45.5 | 86 | 0.044998 | 0.012999 | 12 | 0 | 1 |
no
| 0 | 0 |
no dnr
| 4 | 95 | 6.399414 | 94 | 20 | 37 | null | null | 0.599976 | 1 | 140 | null | 115 | 4 | 3,250 | null | 0 |
<2 mo. follow-up
| 0 |
4,386 | 55.57797 | 0 |
male
| 0 | 23 | 1,034 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
>$50k
| 0 | 103,968 | null | null | 40.333313 |
white
| 29.199219 | 45 | 0.761963 | 0.685913 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 23 | 0 | 15.699219 | 0 | 0 | 37.09375 | 159.15625 | null | 0.899902 | 1.199951 | 127 | 7.379883 | 249 | 20 | 420 | null | 6 |
no(M2 and SIP pres)
| 6 |
4,387 | 46.73499 | 1 |
male
| 0 | 4 | 100 |
Colon Cancer
|
Cancer
| 1 | 13 |
$11-$25k
| 0 | 3,267 | null | null | 11 |
white
| 13.298828 | 9 | 0.884888 | 0.73999 | 1 | 0 | 0 |
metastatic
| 0.65 | 0.35 |
no dnr
| 4 | 69 | 9.199219 | 80 | 26 | 36.5 | 260 | null | null | 6.799805 | 130 | 7.339844 | 100 | 82 | 0 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,388 | 64.047 | 1 |
male
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
$11-$25k
| 0 | 28,500 | null | null | 12 |
white
| 26 | 32 | 0.745972 | 0.665894 | 4 | 0 | 0 |
no
| 0.85 | 0.75 |
no dnr
| 11 | 103 | 14.798828 | 64 | 27 | 36.19531 | 227.5 | 4.599609 | 4.199219 | 3.799805 | 147 | 7.359375 | 196 | 104 | 1,120 | 1 | 4 |
<2 mo. follow-up
| 4 |
4,389 | 57.82599 | 1 |
female
| 1 | 13 | 13 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 26,240 | null | null | 30 |
white
| 33.796875 | 51 | 0.42395 | 0.223999 | 1 | 0 | 0 |
yes
| 0.4 | 0.25 |
dnr after sadm
| 9 | 127 | 12 | 116 | 30 | 38 | 283.3125 | 2.599609 | 6.5 | 2.5 | 141 | 7.509766 | 142 | 68 | 1,585 | null | 6 |
<2 mo. follow-up
| 6 |
4,390 | 59.39798 | 1 |
male
| 0 | 17 | 86 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 13 |
$11-$25k
| 0 | 59,896 | null | null | 24.333328 |
white
| 27.597656 | 55 | 0.782959 | 0.652954 | 1 | 1 | 0 |
no
| 0.9 | 0.6 |
no dnr
| 17 | 124 | 17.898438 | 104 | 22 | 36.39844 | 267.5 | 2.399902 | 0.699951 | 0.399963 | 130 | 7.449219 | 111 | 15 | 1,175 | 1 | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,391 | 68.40198 | 1 |
male
| 0 | 13 | 43 |
Colon Cancer
|
Cancer
| 4 | 16 |
>$50k
| 0 | 24,885 | null | null | 16.5 |
white
| 47 | 40 | 0.089996 | 0.003 | 1 | 1 | 0 |
metastatic
| 0.7 | 0.2 |
no dnr
| 13 | 123 | 10.099609 | 124 | 30 | 38 | 188.5625 | null | null | 1.199951 | 142 | 7.269531 | 124 | 29 | 2,745 | 5 | 1 |
<2 mo. follow-up
| 1 |
4,392 | 58.08398 | 1 |
female
| 1 | 11 | 11 |
Coma
|
Coma
| 1 | null | null | 100 | 59,286 | null | null | 26 |
black
| 24.199219 | 42 | 0.155975 | 0.102997 | 22 | 1 | 0 |
no
| 0.7 | 0.1 |
dnr after sadm
| 3 | 69 | 5.099609 | 60 | 16 | 36.59375 | null | null | 1.099854 | 1.399902 | 133 | null | 102 | 23 | 2,175 | null | 0 |
<2 mo. follow-up
| 0 |
4,393 | 77.24298 | 1 |
male
| 0 | 16 | 88 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 19 | null | 0 | 32,418 | null | null | 19.666656 |
white
| 26.898438 | 35 | 0.629883 | 0.44696 | 4 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 16 | 81 | 8.599609 | 76 | 16 | 36 | null | 4 | 0.399963 | 0.899902 | 143 | null | 99 | 9 | null | null | 2 | null | 2 |
4,394 | 71.66296 | 1 |
male
| 0 | 14 | 218 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 |
under $11k
| 0 | 33,404 | null | null | 14 |
white
| 15.699219 | 8 | 0.850952 | 0.799927 | 8 | 1 | 0 |
no
| 0.5 | 0.5 |
dnr before sadm
| 0 | 50 | 15.398438 | 64 | 16 | 37.89844 | 314.25 | 3.199707 | null | 1.099854 | 137 | 7.429688 | 118 | 13 | 3,060 | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
4,395 | 67.57599 | 1 |
male
| 0 | 10 | 1,029 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | null | null | 0 | 9,614 | null | null | 5.5 |
white
| 14.699219 | 16 | 0.87793 | 0.796997 | 1 | 0 | 0 |
yes
| null | null |
no dnr
| 10 | 71 | 7.899414 | 66 | 18 | 36.5 | 328.5625 | null | 0.699951 | 1.399902 | 140 | 7.40918 | 88 | 22 | null | null | null | null | 2.745117 |
4,396 | 47.51797 | 0 |
male
| 0 | 13 | 1,029 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
under $11k
| 9 | 30,760 | null | null | 16.5 |
black
| 29.296875 | 50 | 0.748901 | 0.669922 | 2 | 0 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 13 | 121 | 6.599609 | 124 | 10 | 34.59375 | 186 | 1.899902 | 5.5 | 1 | 132 | 7.429688 | 268 | 15 | 2,350 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,397 | 26.045 | 0 |
male
| 0 | 31 | 1,029 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 9 | null | 0 | null | null | null | 40.75 |
black
| 41.5 | 80 | 0.587891 | 0.478943 | 1 | 0 | 0 |
yes
| 0.1 | 0.1 | null | null | 51 | 12 | 114 | 24 | 38.19531 | 276.625 | null | null | 3.399902 | 133 | 7.399414 | 296 | 57 | 3,085 | null | 5 |
no(M2 and SIP pres)
| 5 |
4,398 | 68.10394 | 0 |
female
| 0 | 19 | 1,029 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 8 |
under $11k
| 0 | 24,701 | null | null | 7 |
black
| 23.898438 | 30 | 0.802979 | 0.681885 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 19 | 66 | 95.296875 | 120 | 32 | 37.5 | 118.35938 | 2.799805 | 2.5 | 3.599609 | 142 | 7.329102 | 90 | 59 | 1,285 | 2 | 2 |
SIP>=30
| 2 |
4,399 | 88.20795 | 1 |
female
| 0 | 12 | 23 |
Coma
|
Coma
| 1 | null | null | 100 | 6,887 | null | null | 7.5 |
black
| 18.898438 | 28 | 0.134979 | 0.085999 | 1 | 0 | 0 |
no
| 0.05 | 0.02 |
dnr after sadm
| 1 | 147 | 8.898438 | 70 | 24 | 36.09375 | 404 | null | 0.899902 | 0.899902 | 142 | 7.40918 | 179 | 23 | 5,150 | null | 2 |
<2 mo. follow-up
| 2 |
4,400 | 65.84497 | 1 |
male
| 0 | 4 | 61 |
Lung Cancer
|
Cancer
| 1 | 5 |
$11-$25k
| 0 | 4,475 | null | null | null |
black
| 16.597656 | 11 | 0.69397 | 0.403992 | 2 | 0 | 0 |
metastatic
| 0.8 | 0.7 |
no dnr
| 4 | 55 | 7.899414 | 104 | 22 | 37.79688 | 122 | null | 0.5 | 1.299805 | 147 | 7.429688 | 191 | 15 | 1,975 | null | 0 | null | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.